Nano Agriculture

Genomic Valley Biotech Ltd.

GVBL

Market Cap
₹10 Cr.
P/E
339.66

Genomic Valley Biotech Ltd.

  • Genomic Valley Bio.
  • Camson Bio
  • Tarai Foods

FAQs on Genomic Valley Biotech Ltd. Shareprice

Genomic Valley Bio. has given lower returns compared to its competitors.
Genomic Valley Bio. has grown at ~-35.32% over the last 1yrs while peers have grown at a median rate of -16.27%

Yes, Genomic Valley Bio. is expensive.
Latest PE of Genomic Valley Bio. is 339, while 3 year average PE is 102.
Also latest EV/EBITDA of Genomic Valley Bio. is 216 while 3yr average is 96.73.

View FAQ's On Business

Growth Table

  • Genomic Valley Biotech Ltd.
  • Camson Bio
  • Tarai Foods

Balance Sheet

  • Genomic Valley Biotech Ltd.
  • Camson Bio
  • Tarai Foods

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Genomic Valley Biotech Ltd.
  • Camson Bio
  • Tarai Foods

Cash Flow

  • Genomic Valley Biotech Ltd.
  • Camson Bio
  • Tarai Foods

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Genomic Valley Biotech Ltd.
  • Camson Bio
  • Tarai Foods

Quarterly Results

  • Genomic Valley Biotech Ltd.
  • Camson Bio
  • Tarai Foods

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Genomic Valley Biotech Ltd. Financials

Balance sheet of Genomic Valley Bio. is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Genomic Valley Bio. is increasing.
Latest net debt of Genomic Valley Bio. is -₹0.03 Crs as of Mar-26.
This is greater than Mar-25 when it was -₹0.07 Crs.

The profit is oscillating.
The profit of Genomic Valley Bio. is ₹0.36 Crs for Mar 2025, ₹0.02 Crs for Mar 2024 and ₹0.65 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Genomic Valley Bio. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech